Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone add-on to prevent dexamethasone-related neuropsychiatric effects in brain tumor surgery patients
NL-OMON54782Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydrocortisone and dexamethasone in glucocorticoid-induced neuropsychiatric disorder (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Neuropsychiatric adverse effects by Brief Psychiatric Rating Scale. Started Sep 2019; status: completed.
02
Drugs
hydrocortisonedexamethasone
03
Conditions
glucocorticoid-induced neuropsychiatric disorder
Beyond the preview
Go deeper on NL-OMON54782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54782.